Drug and alcohol testing programs are often viewed as an operational or safety initiative. While this is true, the decision to invest in a testing program — or to upgrade an existing one — is ultimately a board-level decision with significant implications for risk management, financial performance, regulatory compliance, and organisational reputation.

This article provides a framework for presenting the business case for a drug and alcohol testing program to a board or executive team, using the language and metrics that matter at that level.

WHS Liability Reduction

Under the Work Health and Safety Act 2011, persons conducting a business or undertaking (PCBUs) have a primary duty of care to ensure, so far as is reasonably practicable, the health and safety of workers. Officers of the PCBU have a separate, personal duty of due diligence.

A drug and alcohol testing program is one of the most direct and demonstrable ways to discharge these obligations as they relate to substance-related risk. In the event of a workplace incident involving substance impairment, one of the first questions a regulator, coroner, or court will ask is: “What did the organisation do to manage this risk?”

The answer “We had no testing program” is difficult to defend. The answer “We had a comprehensive program including random testing, for-cause testing, and post-incident testing, with documented results and a clear policy” is significantly stronger.

For board members, the key message is this: a testing program does not eliminate WHS liability, but it materially reduces it by demonstrating proactive risk management.

Insurance Implications

Insurers are increasingly factoring drug and alcohol testing programs into their assessment of workplace risk. This affects both the availability and the cost of insurance coverage.

• Workers’ compensation premiums — organisations with higher claims frequency and severity pay higher premiums. Substance-related incidents contribute to both. A testing program that reduces these incidents can, over time, reduce premium costs.
• Public liability and professional indemnity — if a substance-impaired worker causes injury or damage to a third party, the insurer will scrutinise the organisation’s risk management practices. The absence of a testing program may be a factor in coverage disputes.
• Self-insurer requirements — organisations that are self-insured for workers’ compensation are required to demonstrate robust safety management systems, which typically include drug and alcohol testing.

Board members should be aware that insurance is not just about premium costs — it is about the organisation’s ability to obtain and maintain adequate coverage. An insurer that perceives unmanaged substance risk may impose exclusions or decline to renew.

Workers’ Compensation Cost Data

Safe Work Australia data consistently shows that substance use is a contributing factor in a significant proportion of workplace injuries and fatalities. While precise figures vary by industry and year, the financial impact is substantial:

• Direct costs — workers’ compensation claims arising from substance-related incidents include medical expenses, rehabilitation costs, income replacement payments, and lump-sum settlements. A single serious injury claim can cost hundreds of thousands of dollars.
• Indirect costs — for every dollar of direct cost, organisations typically incur two to five dollars in indirect costs, including investigation time, equipment damage, replacement labour, production delays, and management time.
• Experience rating — in most Australian jurisdictions, workers’ compensation premiums are experience-rated. A pattern of substance-related claims will directly increase the organisation’s premium for years to come.

Presenting these figures in the context of the organisation’s own claims history — even if substance involvement has not been formally identified in past claims — provides a compelling financial argument.

Productivity Impact

The productivity costs of substance use in the workplace extend well beyond the incidents that result in injury or property damage. Research indicates that substance-affected workers exhibit:

• Higher rates of absenteeism.
• Increased presenteeism (attending work but performing below capacity).
• Higher turnover and associated recruitment and training costs.
• Increased interpersonal conflict and team dysfunction.
• Greater use of sick leave and personal leave.

The Australian Institute of Health and Welfare estimates that alcohol and drug use costs the Australian economy billions of dollars annually in lost productivity. While translating this to a single organisation’s bottom line requires assumptions, the direction is clear: substance use reduces productivity, and a testing program that deters use during and around work hours protects it.

Reputational Risk

A serious incident involving a substance-impaired worker can cause reputational damage that far exceeds the direct financial cost. Media coverage of a workplace fatality where substance use was a factor — particularly if the employer had no testing program in place — can affect:

• Client and customer confidence.
• The organisation’s ability to win contracts and tenders (many major clients now require evidence of a testing program as a condition of engagement).
• Ability to recruit and retain talent.
• Regulatory scrutiny and the likelihood of prosecution.

Reputational risk is difficult to quantify, but board members understand it intuitively. A testing program is a form of reputational insurance.

Regulatory Compliance

Beyond WHS legislation, specific industries and regulatory frameworks require or strongly encourage drug and alcohol testing:

• Mining — state mining safety legislation and major mine operators’ site access requirements typically mandate testing.
• Transport — the National Heavy Vehicle Regulator framework and chain of responsibility obligations make testing a practical necessity.
• Rail — the Rail Safety National Law includes specific drug and alcohol management requirements.
• Aviation — CASA regulations require operators to have drug and alcohol management plans.
• Maritime — AMSA regulations include drug and alcohol testing requirements for certain maritime workers.

For organisations operating in these sectors, a testing program is not optional — it is a condition of operating lawfully.

Building the ROI Framework

A board-level business case should include a clear ROI framework. This does not need to be precise to the dollar — it needs to be credible and directionally correct. A simple framework includes:

• Program costs — testing equipment or provider fees, software, training, collector costs, and management time.
• Avoided costs — estimated reduction in workers’ compensation claims, avoided productivity losses, reduced absenteeism, and the value of incidents prevented.
• Risk reduction — the reduction in WHS liability exposure, insurance premium savings, and regulatory compliance value.
• Qualitative benefits — improved workplace culture, enhanced reputation, and employee confidence in the organisation’s commitment to safety.

Present the ROI over a three-to-five-year horizon, as the benefits of a testing program compound over time as the deterrent effect takes hold and claims history improves.

Making the Case

Board members respond to clarity, data, and pragmatism. Present the business case with a focus on risk reduction, financial impact, and regulatory necessity. Avoid emotional appeals and instead let the data speak for itself.

If you are building the case for a testing program and need a platform that makes implementation straightforward and cost-effective — start your free trial with FairTest and demonstrate to your board that effective testing management is within reach.